Routine

Colonic polyps — post-polypectomy surveillance

Polyp surveillance · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

After complete adenoma/serrated polyp removal, risk-stratified colonoscopic surveillance targets patients with high-risk findings, while most low-risk patients return to routine screening — reducing unnecessary colonoscopy.

Red flags

  • Malignant polyp with adverse histology
  • Incomplete resection of a large lesion
  • Large serrated lesion or serrated polyposis
  • Poor bowel prep limiting detection (repeat sooner)

Assessment

Differential diagnosis

  • Adenomatous polyps (tubular, tubulovillous, villous)
  • Serrated lesions (sessile serrated lesion, traditional serrated adenoma, hyperplastic)
  • Malignant polyp (invasive)
  • Inflammatory/pseudopolyps
  • Hereditary polyposis syndrome

Investigations

  • Complete colonoscopy with removal and retrieval of all polyps
  • Histology of all resected lesions (size, number, dysplasia, villous/serrated features)
  • Documentation of completeness of resection and bowel prep quality
  • Consider genetics referral if numerous polyps or young age
  • CT colonography if colonoscopy incomplete

Management

  • Ensure complete, high-quality index colonoscopy with adequate preparation and caecal intubation
  • Resect and retrieve all polyps for histology
  • Classify findings by number, size (≥10 mm), and high-risk histology (villous, high-grade dysplasia, serrated)
  • Define high-risk: ≥2 premalignant polyps including an advanced one, or ≥5 premalignant polyps
  • Offer a surveillance colonoscopy (e.g. at 3 years) to high-risk patients
  • Return low-risk patients to routine (FIT) screening rather than short-interval colonoscopy
  • Arrange earlier repeat if index examination incomplete or piecemeal resection of a large lesion
  • Perform site check/repeat for large (≥20 mm) piecemeal endoscopic resections at 2–6 months
  • Refer malignant polyps with adverse features for MDT/surgical discussion
  • Consider polyposis syndromes if polyp burden is high or patient is young
  • Document the agreed surveillance plan and recall clearly

Drugs & doses

No specific pharmacotherapy — surveillance is endoscopic
Bowel preparation for colonoscopy (e.g. macrogol-based)

Disposition

Endoscopy surveillance register with clear recall; MDT for malignant polyps.

Complications & pitfalls

  • Interval cancer (missed/inadequately resected lesions)
  • Post-polypectomy bleeding or perforation
  • Over-surveillance (procedural risk, cost)
  • Recurrence at large resection sites

Exam pearls

  • Most patients after polypectomy do NOT need short-interval colonoscopy — return low-risk cases to routine screening
  • High-risk findings (advanced adenoma, multiple polyps) drive the need for 3-year surveillance
  • Large piecemeal resection sites need an early (2–6 month) site check
  • Quality of the index colonoscopy (prep, caecal intubation, complete resection) determines surveillance reliability

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.